ActiveNCT07576946

Development and Pilot Evaluation of an Artificial Intelligence-Assisted System for Automated Oxygen Flow Regulation: The Saturista Device

Sponsor: Koç University

Trial Details

ConditionOxygen Therapy
StatusActive
Participants7
Est. Completion1 June 2026
Last Updated8 May 2026

Primary Outcome

Real-Time Data Display Performance

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Healthy adult volunteers aged 18 years or older * Resting oxygen saturation (SpO₂) within the normal range at baseline * Ability to understand the study procedures and provide written informed consent * Willingness to participate in all planned testing scenarios Exclusion Criteria: * History of chronic respiratory disease, including asthma, chronic obstructive pulmonary disease, or interstitial lung disease * Known cardiovascular disease or any condition that may affect oxygen saturation or hemodynamic stability * Current respiratory symptoms, acute infection, or fever at the time of participation * Anemia, peripheral circulatory disorders, or any condition that may interfere with pulse oximetry measurements * Skin lesions, deformity, or injury at the intended probe placement site * Pregnancy * History of syncope, intolerance to short-duration breath-holding, or any condition that may increase risk during testing * Inability or unwillingness to comply with study procedures

Trial Sites

Countries

Turkey (Türkiye)
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service